These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6723311)
1. Effect of aspirin on the luteal phase of human menstrual cycle. Souka AR; Medhat M; Rahman HA; Osman M; El Sokkary H Contraception; 1984 Feb; 29(2):181-8. PubMed ID: 6723311 [TBL] [Abstract][Full Text] [Related]
2. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630 [TBL] [Abstract][Full Text] [Related]
3. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation. Croxatto HB; Salvatierra AM; Romero C; Spitz IM J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656 [TBL] [Abstract][Full Text] [Related]
5. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays. Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896 [TBL] [Abstract][Full Text] [Related]
6. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [TBL] [Abstract][Full Text] [Related]
7. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322 [TBL] [Abstract][Full Text] [Related]
8. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function. Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920 [TBL] [Abstract][Full Text] [Related]
9. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG. Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478 [TBL] [Abstract][Full Text] [Related]
10. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential. Greene KE; Kettel LM; Yen SS Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899 [TBL] [Abstract][Full Text] [Related]
11. Lowering low density lipoprotein cholesterol with simvastatin, a hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, does not affect luteal function in premenopausal women. Plotkin D; Miller S; Nakajima S; Peskin E; Burkman R; Richardson D; Mitchel Y; Waldstreicher J; Liu M; Shapiro D; Santoro N J Clin Endocrinol Metab; 2002 Jul; 87(7):3155-61. PubMed ID: 12107216 [TBL] [Abstract][Full Text] [Related]
12. The prediction and/or detection of ovulation by means of urinary steroid assays. Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775 [TBL] [Abstract][Full Text] [Related]
13. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle. Grimes EM; Thompson IE; Taymor ML Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349 [TBL] [Abstract][Full Text] [Related]
14. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle. Stanczyk FZ; Miyakawa I; Goebelsmann U Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528 [TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH. Faure N; Olivier GC Horm Res; 1978; 9(1):12-21. PubMed ID: 338460 [TBL] [Abstract][Full Text] [Related]
16. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women. Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914 [TBL] [Abstract][Full Text] [Related]
17. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076 [TBL] [Abstract][Full Text] [Related]
18. Relationship of luteinizing hormone, pregnanediol-3-glucuronide, and estriol-16-glucuronide in urine of infertile women with endometriosis. Cheesman KL; Ben-Nun ; Chatterton RT; Cohen MR Fertil Steril; 1982 Nov; 38(5):542-8. PubMed ID: 7128839 [TBL] [Abstract][Full Text] [Related]
19. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles. Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744 [TBL] [Abstract][Full Text] [Related]
20. Investigation of Danazol as a contraceptive agent. Wentz AC; Jones GS; Sapp KC Contraception; 1976 May; 13(5):619-30. PubMed ID: 1261264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]